CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

11 hedge funds and large institutions have $159K invested in Can-Fite BioPharma in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership: →

69% less capital invested

Capital invested by funds: $518K → $159K (-$359K)

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$31K
2
+$24K
3
+$23K
4
Citadel Advisors
Citadel Advisors
Florida
+$21K
5
Envestnet Asset Management
Envestnet Asset Management
Illinois
+$3.49K

Top Sellers

1
-$392K
2
-$32.3K
3
-$20K
4
UBS Group
UBS Group
Switzerland
-$6K
5
PAG
Private Advisor Group
New Jersey
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$31K
2
$25K
3
$24K
4
$24K
5
$23K
6
$21K
7
$9K
8
$1K
9
$943
10
–
11
–
12
–
13
–